Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement

被引:28
作者
Dantas, Andrea Tavares [1 ,2 ]
Calado Goncalves, Sayonara Maria [1 ]
Pereira, Michelly Cristiny [1 ]
Guimaraes Goncalves, Rafaela Silva [1 ,2 ]
Lopes Marques, Claudia Diniz [2 ]
Barreto de Melo Rego, Moacyr Jesus [1 ]
Pitta, Ivan da Rocha [1 ]
Branco Pinto Duarte, Angela Luzia [2 ]
da Rocha Pitta, Maira Galdino [1 ]
机构
[1] Lab Imunomodulacao & Novas Abordagens Terapeut, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Hosp Clin, Serv Reumatol, Recife, PE, Brazil
关键词
Cytokine; Interleukin-35; Pulmonary fibrosis; Systemic sclerosis; REGULATORY T-CELLS; INDUCED ARTHRITIS; TH17; CELLS; CYTOKINES;
D O I
10.1007/s10067-015-3006-y
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The objective of this study is to assess the serum IL-35 level and its association with clinical manifestations in patients with systemic sclerosis (SSc). IL-35 serum levels were measured by ELISA from 56 patients with SSc and 53 healthy controls. Association of IL-35 serum levels were sought with clinical parameters. Serum IL-35 levels were significantly higher in SSc patients (5.08 +/- 0.76 pg/ml) than in healthy individuals (1.89 +/- 0.69 pg/ml; p < 0.0001). Patients with lung fibrosis had higher IL-35 levels than those without fibrosis (7.75 +/- 1.36 and 3.08 +/- 0.70 pg/ml, respectively, p = 0.0022). IL-35 is elevated in the serum of patients with SSc and is associated with lung fibrosis. Our findings suggest that this cytokine can have a role in fibrotic diseases, but further studies are needed to address the role of IL-35 in the pathogenesis of SSc.
引用
收藏
页码:1621 / 1625
页数:5
相关论文
共 20 条
[1]
PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines [J].
Banchereau, Jacques ;
Pascual, Virginia ;
O'Garra, Anne .
NATURE IMMUNOLOGY, 2012, 13 (10) :925-931
[3]
Human CD4+CD25+Foxp3+ Regulatory T Cells Do Not Constitutively Express IL-35 [J].
Bardel, Emilie ;
Larousserie, Frederique ;
Charlot-Rabiega, Pascaline ;
Coulomb-L'Hermine, Aurore ;
Devergne, Odile .
JOURNAL OF IMMUNOLOGY, 2008, 181 (10) :6898-6905
[4]
CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
[5]
The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J].
Collison, Lauren W. ;
Workman, Creg J. ;
Kuo, Timothy T. ;
Boyd, Kelli ;
Wang, Yao ;
Vignali, Kate M. ;
Cross, Richard ;
Sehy, David ;
Blumberg, Richard S. ;
Vignali, Dario A. A. .
NATURE, 2007, 450 (7169) :566-U19
[6]
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases [J].
Fenoglio, Daniela ;
Bernuzzi, Francesca ;
Battaglia, Florinda ;
Parodi, Alessia ;
Kalli, Francesca ;
Negrini, Simone ;
De Palma, Raffaele ;
Invernizzi, Pietro ;
Filaci, Gilberto .
AUTOIMMUNITY REVIEWS, 2012, 12 (02) :300-304
[7]
Filkova M, 2010, ARTHRITIS RHEUM S10, V62
[8]
Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis Correlations with disease severity and phenotypes [J].
Giovannetti, Antonello ;
Rosato, Edoardo ;
Renzi, Cristina ;
Maselli, Angela ;
Gambardella, Lucrezia ;
Giammarioli, Anna Maria ;
Palange, Paolo ;
Paoletti, Patrizia ;
Pisarri, Simonetta ;
Salsano, Felice ;
Malorni, Walter ;
Pierdominici, Marina .
CLINICAL IMMUNOLOGY, 2010, 137 (01) :122-133
[9]
Pulmonary Toxicity After Initiation of Azathioprine for Treatment of Interstitial Pneumonia in a Patient with Rheumatoid Arthritis [J].
Ishida, Takaaki ;
Kotani, Takuya ;
Takeuchi, Tohru ;
Makino, Shigeki .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (05) :1104-1106
[10]
Correlation of Th17 cells and CD4+CD25+ regulatory T cells with clinical parameters in patients with systemic sclerosis [J].
Jiang Nan ;
Li Mengtao ;
Zeng Xiaofeng .
CHINESE MEDICAL JOURNAL, 2014, 127 (20) :3557-3561